Aclaris Therapeutics

About:

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

Website: http://www.aclaristx.com

Top Investors: RA Capital Management, F-Prime Capital, Cormorant Asset Management, Sofinnova Investments, Samsara BioCapital

Description:

Aclaris Therapeutics started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development of novel dermatologic therapies. It is committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. Aclaris is focused on market segments with no FDA-approved medications or where treatment gaps exist.

Total Funding Amount:

$300M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Malvern, Pennsylvania, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)aclaristx.com

Founders:

Frank Ruffo, Kamil Ali-Jackson, Neal Walker, Stuart D. Shanler

Number of Employees:

101-250

Last Funding Date:

2024-11-18

IPO Status:

Public

Industries:

© 2025 bioDAO.ai